FMR LLC 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-03-10 09:48 am Sale | 2022-03-09 | 13G | Kura Oncology, Inc. KURA | FMR LLC | 241,463 0.362% | -5,340,737![]() (-95.67%) | Filing |
2022-01-10 1:26 pm Sale | 2022-01-07 | 13G | Kura Oncology, Inc. KURA | FMR LLC | 5,582,200 8.387% | -3,533,840![]() (-38.77%) | Filing |
2021-02-08 10:27 am Purchase | 2021-02-05 | 13G | Kura Oncology, Inc. KURA | FMR LLC | 9,116,040 13.821% | 2,318,838![]() (+34.11%) | Filing |